Rumany C. Penn

FDA investigator · also recorded as Pais Rumany C. Penn

Appears on 21 documents from 2016 to 2022, most often at sites in California. Most often cites design and construction features (21 CFR 211.42).

21
Documents on file
4.2
Observations per 483
2016
First seen
2022
Most recent

What they cite most

From 89 observations

Activity by year

2016: 1, 2017: 4, 2018: 5, 2019: 7, 2020: 3, 2022: 1

Where

California 6 · India 4 · Nevada 4 · China 2 · Japan 2 · Arizona 1

Is Rumany C. Penn coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

21 documents, newest first
FirmOpen
483 Eisai Co., Ltd.Nov 18, 2022 · Kamisu-shi, Japan
483 TECHNICHEM CORPMar 18, 2020 · ANAHEIM, California
483 Innovative lntrathecal Solutions, Inc. dbauFeb 20, 2020 · Murrieta, California
483 NuCare Pharmaceuticals,Inc.Jan 10, 2020 · ORANGE, California
483 Shandong Luxi Pharmaceutical Co., Ltd.Jul 24, 2019 · Heze, China
483 Zhuhai United Laboratories Co., LtdJul 16, 2019 · Zhuhai, China
483 Strides Pharma Science LimitedMay 24, 2019 · Bengaluru, India

About this profile

What does Rumany C. Penn inspect?

Rumany C. Penn appears on 21 documents on file covering 21 sites, most often in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rumany C. Penn is dated Nov 18, 2022.